BEI Medical Receives FDA Approval to Market New Model of HTA System for Treating Dysfunctional Uterine Bleeding.Business Editors TETERBORO, N.J.--(BUSINESS WIRE)--July 31, 2001 BEI Bei (pā, bā), river, c.200 mi (320 km) long, formed by the union of two headstreams in the Nanling Mts., N Guangdong prov., S China. It flows S into the Xi River, E of Guangzhou, to form the Pearl River delta. Medical Systems Company, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BMED BMED British Mediterranean Airways BMed Bachelor of Medicine BMEd Bachelor of Mathematics Education ), announced today that it has received approval from the U. S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) to market in the U.S. a lighter weight, smaller, and more transportable version of its Hydro ThermAblator(R), or HTA(R), a minimally invasive system for treating menorrhagia menorrhagia /men·or·rha·gia/ (men?ah-ra´jah) hypermenorrhea. men·or·rha·gia n. See hypermenorrhea. , or dysfunctional uterine bleeding Dysfunctional Uterine Bleeding Definition Dysfunctional uterine bleeding is irregular, abnormal uterine bleeding that is not caused by a tumor, infection, or pregnancy. . Approval of the new model was based on a Real Time Review Supplement submitted to the FDA last month. The new model of the HTA(R) is a next generation version of the company's proprietary system, which was first approved by the FDA on April 20, 2001. It is especially well suited for physicians' offices and same day surgery centers where space, storage and portability are primary concerns, while at the same time reducing the component and assembly costs of the unit. Richard Turner, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of BEI Medical, said, "We believe physicians will welcome the scheduling flexibility and convenience they can enjoy by using our second generation HTA to perform endometrial ablation in their offices or surgery centers. We anticipate that the new unit will also enhance the marketing opportunities for expanding the nationwide network of independent sales representatives we have established," Turner added. BEI Medical Systems Company, Inc., is a company focused on gynecology. The company has received approval from the FDA to market in the United States its sole product, the Hydro ThermAblator, or HTA, a proprietary system that is intended to treat menorrhagia, or dysfunctional uterine bleeding. BEI Medical Systems(R), Hydro ThermAblator(R) and HTA(R) are registered trademarks of BEI Medical Systems Company, Inc. in the United States and certain foreign countries. Except for historical information, this news release may be deemed to contain forward-looking statements that involve risks and uncertainties, including statements with respect to: acceptance and pricing of the HTA system; the impact of competitive products and pricing; the company's ability to raise additional capital on terms favorable to the company, or at all; and general economic conditions as they affect BEI Medical's customers, as well as other risks detailed from time to time in the company's reports to the Securities and Exchange Commission, including the company's Form 10-K annual report. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion